CIL has the capabilities to supply compounds suitable for all different phases of clinical trials. Each cGMP product is manufactured, tested, packaged and released according to current Good Manufacturing Practice. Customers can be assured that they will receive a wide range of support throughout each cGMP project.
CK Isotopes Ltd. specialises in supplying stable isotopes for clinical work in the United Kingdom and Ireland. We have close ties with current academic research as well as the MHRA, NHS and various 3rd party pharmacy services. This enables us to know exactly what is required and what specification will meet the criteria for your application. If you are planning to do any clinical work then we recommend speaking to us as soon as possible as the process with pharmacy approval can take some time. Demonstrating QC pre-approval can also be helpful in grant applications and eliminates risks of raw material and preparation issues once the study has commenced. We are able to tailor every element of the specification to meet your need.
Below is an important document that will be helpful in deciding which grade you will need for your application and should be discussed with pharmacy during the planning phase. Additional information is available on request and we are always happy to talk through it with you via our contact page or over the phone.
Research Use Statement
Describes differences between material grade.
Other useful documents
These are articles written by our customers for specific applications as well as a few useful datasheets.
- Stable Isotopes in Drug Development and Personalized Medicine
- Stable Isotope Labeling Kinetics (SILK™) to Measure the Metabolism of Brain-Derived Proteins Implicated in Neurodegeneration
- Heavy-Labeled MS Protein Standard Human ApoA-1 (15N, 98%) Datasheet
- Heavy-Labeled MS Protein Standard Human IGF-1 Datasheet
Got a Question?
For information please start your enquiry below: